AdvertiseDonate
Saturday, November 21, 2026Local news for Dallas County, Texas.
Dallas County Herald · 3838 Oak Lawn Avenue, Suite 1000, Dallas, TX 75219

Veterans advocates cheer federal push to study ibogaine as PTSD treatment

Federal health officials announced up to $4.9 million to lay the groundwork for U.S. clinical trials of the psychoactive drug ibogaine, drawing praise from veterans groups.

By Valentina Cruz ·

Illustration for: Veterans advocates cheer federal push to study ibogaine as PTSD treatment
Illustration generated for this article, not a news photograph.

Veterans advocates on Thursday welcomed a federal commitment to advance the psychoactive drug ibogaine as a possible treatment for post-traumatic stress disorder. The departments of Health and Human Services and Veterans Affairs jointly announced up to $4.9 million in funding to support the scientific, regulatory and manufacturing work needed to prepare for future U.S. clinical trials of ibogaine for PTSD.

Health Secretary Robert F. Kennedy Jr. said the initial commitment spans five years and that the Advanced Research Projects Agency for Health, known as ARPA-H, also intends to fund additional research into ibogaine as a potential treatment for substance use disorders and other conditions. Officials stressed that the awards cover early development work only. They do not pay for patient treatment or human-subject research, do not authorize clinical trials and do not amount to Food and Drug Administration approval.

"Researchers must establish whether ibogaine can help patients, identify who might benefit, determine whether those benefits justify the risks," Kennedy said at a news conference. "They must also investigate how long any improvement lasts. We will judge this work by the quality of the evidence."

Kennedy also announced that the National Institute of Mental Health has opened a $20 million funding opportunity to create a research network focused on rapid-acting psychotropic interventional drugs, including ketamine, esketamine, psilocybin and other emerging treatments for serious mental illness. He said the efforts follow President Donald Trump's April order to accelerate new medical treatments, including psychedelic drugs, for serious mental illness. Noting that the announcements came a day after Veterans Day, Kennedy said, "Our responsibility includes investing in research that could improve their care and giving vets accurate information about potential treatments."

Kyleanne Hunter, CEO of Iraq and Afghanistan Veterans of America, praised the move. "We think it's a great thing for veterans anytime we are able to invest in new and promising treatments that may help with PTSD," she said, adding that PTSD is a complex condition and no stone should be left unturned in searching for help.

Jim Whaley, CEO of the advocacy group Mission Roll Call, also called the announcements good news. "We ran a survey in May of this year. It went to a large number of veterans, and 75% said they supported greater VA involvement in clinical trials involving this treatment in particular," Whaley said. "Only 2% opposed." He said the group's surveys show veterans want access to psychedelic treatments paired with rigorous scientific study, and that effective ibogaine treatment could help reduce veteran homelessness and suicide, two of his organization's priorities.

Whaley said the sight of HHS and VA tackling PTSD together is encouraging. "When you're suffering from post-traumatic stress and you're on a slippery slope of depression, you want action to occur," he said. "And I think in many cases, some treatments have just taken too long to get to trials, too long to get in the hands of veterans. And this seems to show that there's a sense of urgency."

No large-scale clinical trials of ibogaine for PTSD have been conducted so far, but Hunter said anecdotal evidence suggests it could be a useful tool, especially alongside other forms of treatment such as therapy. "There's a ton of promise to these tools, but they're not standalone magic bullets," she said. She noted that existing evidence rests largely on studies of special operations soldiers and said she wants future research to span the full range of service members and veterans.

Hunter said she suspects psychedelic treatments remain a few years away for veterans, and that the wait is acceptable if that is what proper safety and efficacy testing requires. Veterans who are struggling can reach the Veterans Crisis Line around the clock, free and confidentially, by dialing 988 and pressing 1, chatting at VeteransCrisisLine.net/Chat, or texting 838255.

Originally published by News Media House

More News · Mission news · Report a business · Got a Story?

Get Dallas County Herald in your inboxLocal news for Dallas County, Texas. Free, a few times a week, unsubscribe any time.

Get Dallas County Herald in your inboxLocal news for Dallas County, Texas. Free, a few times a week, unsubscribe any time.